We help bring a medicine to the Uzbekistan market — from registration strategy to obtaining the registration certificate. We prepare the dossier, support the expert review and handle communication with the authorities.
Why it matters
Importing and selling a medicine without state registration is prohibited. A product undergoes a review of quality, safety and efficacy — and clinical trials where required — and only receives a registration certificate after being entered into the State Register.
New registration and clinical-trial rules
From 2025–2026 the registration procedure has been updated. Resolution of the Cabinet of Ministers No. 738 of 24 November 2025 approved the regulation on the state registration of medicines: requirements, the document list and the step-by-step procedure via the Center for Pharmaceutical Product Safety under the Ministry of Health.
The clinical-trial procedure is set by Order of the Minister of Health No. 3745, in force from 26 February 2026. It harmonises national procedures with international ICH and GxP requirements.
- 📄 Download Resolution No. 738 — registration of medicines and devices (EN, .docx)
- 📄 Download Order No. 3745 — clinical trials procedure (in Russian, .docx)
How registration works
- Assessment of the product and dossier, choice of registration strategy
- Preparation and completion of the registration dossier
- Submission to the authority and support through the quality, safety and efficacy review
- Clinical trials or bioequivalence assessment — where required
- Entry into the State Register and issuance of the registration certificate
Why us
We know the procedure inside out and stay in contact with the authorities. We support the product at every stage — from dossier analysis to the certificate — and keep timelines under control. You don’t lose time on mistakes: we get it right the first time.
Ready to start?
Send us the product name, dosage form and country of origin — we’ll assess the registration route and timelines for free.